Annual Interest Expense
$2.07 M
+$377.30 K+22.27%
31 December 2023
Summary:
Aldeyra Therapeutics annual interest expense is currently $2.07 million, with the most recent change of +$377.30 thousand (+22.27%) on 31 December 2023. During the last 3 years, it has risen by +$167.20 thousand (+8.78%). ALDX annual interest expense is now at all-time high.ALDX Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Interest Expense
$479.30 K
+$1700.00+0.36%
30 September 2024
Summary:
Aldeyra Therapeutics quarterly interest expense is currently $479.30 thousand, with the most recent change of +$1700.00 (+0.36%) on 30 September 2024. Over the past year, it has dropped by -$59.40 thousand (-11.03%). ALDX quarterly interest expense is now -11.91% below its all-time high of $544.10 thousand, reached on 31 December 2019.ALDX Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Interest Expense
$1.97 M
-$59.40 K-2.93%
30 September 2024
Summary:
Aldeyra Therapeutics TTM interest expense is currently $1.97 million, with the most recent change of -$59.40 thousand (-2.93%) on 30 September 2024. Over the past year, it has dropped by -$48.20 thousand (-2.39%). ALDX TTM interest expense is now -5.24% below its all-time high of $2.08 million, reached on 31 March 2024.ALDX TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALDX Interest Expense Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +22.3% | -11.0% | -2.4% |
| 3 y3 years | +8.8% | +16.0% | +8.3% |
| 5 y5 years | +1311.0% | +1541.4% | +1497.5% |
ALDX Interest Expense High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +22.3% | -11.0% | +18.1% | -5.2% | +19.9% |
| 5 y | 5 years | at high | +1311.0% | -11.9% | +1541.4% | -5.2% | +1497.5% |
| alltime | all time | at high | +1863.4% | -11.9% | >+9999.0% | -5.2% | >+9999.0% |
Aldeyra Therapeutics Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $479.30 K(+0.4%) | $1.97 M(-2.9%) |
| June 2024 | - | $477.60 K(-4.2%) | $2.03 M(-2.4%) |
| Mar 2024 | - | $498.50 K(-3.1%) | $2.08 M(+0.3%) |
| Dec 2023 | $2.07 M(+22.3%) | $514.30 K(-4.5%) | $2.07 M(+2.7%) |
| Sept 2023 | - | $538.70 K(+2.2%) | $2.02 M(+6.4%) |
| June 2023 | - | $527.10 K(+7.3%) | $1.90 M(+6.6%) |
| Mar 2023 | - | $491.30 K(+6.6%) | $1.78 M(+5.0%) |
| Dec 2022 | $1.69 M(-2.8%) | $460.80 K(+10.5%) | $1.69 M(+2.9%) |
| Sept 2022 | - | $416.90 K(+1.6%) | $1.65 M(+0.2%) |
| June 2022 | - | $410.40 K(+1.1%) | $1.64 M(-1.4%) |
| Mar 2022 | - | $406.00 K(-1.7%) | $1.67 M(-4.4%) |
| Dec 2021 | $1.74 M(-8.5%) | $412.90 K(-0.0%) | $1.74 M(-4.2%) |
| Sept 2021 | - | $413.10 K(-4.7%) | $1.82 M(-4.0%) |
| June 2021 | - | $433.50 K(-10.2%) | $1.89 M(-2.7%) |
| Mar 2021 | - | $482.60 K(-1.3%) | $1.95 M(+2.2%) |
| Dec 2020 | $1.90 M(+215.4%) | $489.10 K(-0.0%) | $1.90 M(-2.8%) |
| Sept 2020 | - | $489.20 K(+0.7%) | $1.96 M(+30.7%) |
| June 2020 | - | $486.00 K(+10.5%) | $1.50 M(+43.9%) |
| Mar 2020 | - | $439.80 K(-19.2%) | $1.04 M(+72.5%) |
| Dec 2019 | $603.80 K(+311.3%) | $544.10 K(+1763.4%) | $603.90 K(+389.8%) |
| Sept 2019 | - | $29.20 K(+2.1%) | $123.30 K(+0.3%) |
| June 2019 | - | $28.60 K(+1330.0%) | $122.90 K(+1.8%) |
| Mar 2019 | - | $2000.00(-96.9%) | $120.70 K(-17.7%) |
| Dec 2018 | $146.80 K | $63.50 K(+120.5%) | $146.70 K(+26.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2018 | - | $28.80 K(+9.1%) | $115.80 K(+1.0%) |
| June 2018 | - | $26.40 K(-5.7%) | $114.60 K(-0.1%) |
| Mar 2018 | - | $28.00 K(-14.1%) | $114.70 K(+1.1%) |
| Dec 2017 | $113.50 K(+7.6%) | $32.60 K(+18.1%) | $113.50 K(+6.2%) |
| Sept 2017 | - | $27.60 K(+4.2%) | $106.90 K(+0.8%) |
| June 2017 | - | $26.50 K(-1.1%) | $106.00 K(-1.2%) |
| Mar 2017 | - | $26.80 K(+3.1%) | $107.30 K(+1.7%) |
| Dec 2016 | $105.50 K(-6.1%) | $26.00 K(-2.6%) | $105.50 K(-1.9%) |
| Sept 2016 | - | $26.70 K(-4.0%) | $107.50 K(-1.3%) |
| June 2016 | - | $27.80 K(+11.2%) | $108.90 K(-0.4%) |
| Mar 2016 | - | $25.00 K(-10.7%) | $109.30 K(-2.7%) |
| Dec 2015 | $112.30 K(-54.0%) | $28.00 K(-0.4%) | $112.30 K(-4.7%) |
| Sept 2015 | - | $28.10 K(-0.4%) | $117.90 K(-9.9%) |
| June 2015 | - | $28.20 K(+0.7%) | $130.90 K(-17.6%) |
| Mar 2015 | - | $28.00 K(-16.7%) | $158.90 K(-34.9%) |
| Dec 2014 | $244.20 K(+53.3%) | $33.60 K(-18.2%) | $244.10 K(-24.8%) |
| Sept 2014 | - | $41.10 K(-26.9%) | $324.70 K(+8.9%) |
| June 2014 | - | $56.20 K(-50.4%) | $298.10 K(+15.9%) |
| Mar 2014 | - | $113.20 K(-0.9%) | $257.20 K(+61.4%) |
| Dec 2013 | $159.30 K(-53.4%) | $114.20 K(+687.6%) | $159.40 K(+180.6%) |
| Sept 2013 | - | $14.50 K(-5.2%) | $56.80 K(+34.3%) |
| June 2013 | - | $15.30 K(-0.6%) | $42.30 K(+56.7%) |
| Mar 2013 | - | $15.40 K(+32.8%) | $27.00 K(+132.8%) |
| Dec 2012 | $342.00 K(+22.2%) | $11.60 K | $11.60 K |
| Dec 2011 | $279.90 K | - | - |
FAQ
- What is Aldeyra Therapeutics annual interest expense?
- What is the all time high annual interest expense for Aldeyra Therapeutics?
- What is Aldeyra Therapeutics annual interest expense year-on-year change?
- What is Aldeyra Therapeutics quarterly interest expense?
- What is the all time high quarterly interest expense for Aldeyra Therapeutics?
- What is Aldeyra Therapeutics quarterly interest expense year-on-year change?
- What is Aldeyra Therapeutics TTM interest expense?
- What is the all time high TTM interest expense for Aldeyra Therapeutics?
- What is Aldeyra Therapeutics TTM interest expense year-on-year change?
What is Aldeyra Therapeutics annual interest expense?
The current annual interest expense of ALDX is $2.07 M
What is the all time high annual interest expense for Aldeyra Therapeutics?
Aldeyra Therapeutics all-time high annual interest expense is $2.07 M
What is Aldeyra Therapeutics annual interest expense year-on-year change?
Over the past year, ALDX annual interest expense has changed by +$377.30 K (+22.27%)
What is Aldeyra Therapeutics quarterly interest expense?
The current quarterly interest expense of ALDX is $479.30 K
What is the all time high quarterly interest expense for Aldeyra Therapeutics?
Aldeyra Therapeutics all-time high quarterly interest expense is $544.10 K
What is Aldeyra Therapeutics quarterly interest expense year-on-year change?
Over the past year, ALDX quarterly interest expense has changed by -$59.40 K (-11.03%)
What is Aldeyra Therapeutics TTM interest expense?
The current TTM interest expense of ALDX is $1.97 M
What is the all time high TTM interest expense for Aldeyra Therapeutics?
Aldeyra Therapeutics all-time high TTM interest expense is $2.08 M
What is Aldeyra Therapeutics TTM interest expense year-on-year change?
Over the past year, ALDX TTM interest expense has changed by -$48.20 K (-2.39%)